United States: The U.S. is the leading country market, valued at USD 73.25 Million in 2024. This is attributed to robust healthcare infrastructure and high adoption of premium therapeutics. https://www.databridgemarketresearch.com/nucleus/global-lung-transplant-therapeutics-market